Intensified research in this field showed that of the genes located on the 9p21 deletion and promoter, hypermethylation of CDKN2A and CDKN2B genes has been observed in more than 70% of T-ALL patients. The gene discussed is CDKN2B; the disease is acute lymphoblastic leukemia.